Table of Contents

company-logo

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.

Talis Biomedical Dividend Announcement

• Talis Biomedical does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Talis Biomedical dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Talis Biomedical Dividend History

Talis Biomedical Dividend Yield

Talis Biomedical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Talis Biomedical stock? Use our calculator to estimate your expected dividend yield:

Talis Biomedical Financial Ratios

P/E ratio-0.06
PEG ratio0.02
P/B ratio0.06
ROE-79.73%
Payout ratio0.00%
Current ratio7.76
Quick ratio7.76
Cash Ratio7.30

Talis Biomedical Dividend FAQ

Does Talis Biomedical stock pay dividends?
Talis Biomedical does not currently pay dividends to its shareholders.
Has Talis Biomedical ever paid a dividend?
No, Talis Biomedical has no a history of paying dividends to its shareholders. Talis Biomedical is not known for its dividend payments.
Why doesn't Talis Biomedical pay dividends?
There are several potential reasons why Talis Biomedical would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Talis Biomedical ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Talis Biomedical has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Talis Biomedical a dividend aristocrat?
Talis Biomedical is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Talis Biomedical a dividend king?
Talis Biomedical is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Talis Biomedical a dividend stock?
No, Talis Biomedical is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Talis Biomedical stocks?
To buy Talis Biomedical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Talis Biomedical stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.